Mycophenolate mofetil and Gastroenteritis salmonella - a phase IV clinical study of FDA data

Summary:

Gastroenteritis salmonella is reported as a side effect among people who take Mycophenolate mofetil (mycophenolate mofetil), especially for people who are male, 50-59 old, also take Cyclosporine, and have Nephrotic syndrome.

The phase IV clinical study analyzes which people have Gastroenteritis salmonella when taking Mycophenolate mofetil. It is created by eHealthMe based on reports of 93,176 people who have side effects when taking Mycophenolate mofetil from the FDA, and is updated regularly.

What is Mycophenolate mofetil?

Mycophenolate mofetil has active ingredients of mycophenolate mofetil. It is often used in myasthenia gravis. eHealthMe is studying from 93,460 Mycophenolate mofetil users. Check the latest studies of Mycophenolate mofetil.

What is Gastroenteritis salmonella?

Gastroenteritis salmonella (inflammation of stomach and intestine caused by salmonella bacteria) is found to be associated with 122 drugs and 261 conditions by eHealthMe. Check the latest studies of Gastroenteritis salmonella.

On Jul, 16, 2026

93,176 people reported to have side effects when taking Mycophenolate mofetil.
Among them, 23 people (0.02%) have Gastroenteritis salmonella.

Could Mycophenolate mofetil cause Gastroenteritis salmonella?

Among these 23 people:

What is the gender of people who have Gastroenteritis salmonella when taking Mycophenolate mofetil? *

female: 50 %
male: 50 %

What is the age of people who have Gastroenteritis salmonella when taking Mycophenolate mofetil? *

What are other drugs people take besides Mycophenolate mofetil? *

What are other side effects people have besides Gastroenteritis salmonella? *

Pleural Effusion (water on the lungs): 7 people, 30.43%
Anaemia (lack of blood): 7 people, 30.43%
Pericardial Effusion (fluid around the heart): 7 people, 30.43%
Urinary Tract Infection: 6 people, 26.09%
Aortic Intramural Haematoma: 5 people, 21.74%
Cardiac Tamponade (fluid accumulates in heart covering): 5 people, 21.74%
Respiratory Distress (difficulty in breathing): 5 people, 21.74%
Metabolic Acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body): 5 people, 21.74%
Pneumonia Cytomegaloviral (cmv pneumonia is caused by a member of a group of herpes-type viruses): 5 people, 21.74%
Enlarged Heart: 5 people, 21.74%

What are the existing conditions these people have? *

Nephrotic Syndrome (kidney disease with proteinuria, hypoalbuminemia, and oedema): 3 people, 13.04%
Wernicke's Encephalopathy (ocular disturbances, changes in mental state, unsteady stance and gait due to deficiency of vit.b1): 1 person, 4.35%
Salmonella Enterocolitis (an infection in the lining of the small intestine caused by salmonella bacteria): 1 person, 4.35%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 1 person, 4.35%
Post Procedural Hypothyroidism: 1 person, 4.35%
Intervertebral Discitis (infection in the intervertebral disc space): 1 person, 4.35%
Immunodeficiency Disorders: 1 person, 4.35%
Bone Marrow Conditioning Regimen: 1 person, 4.35%
Aplastic Anemia: 1 person, 4.35%

* Approximation only. Some reports may have incomplete information.

Do you take Mycophenolate mofetil and have Gastroenteritis salmonella?

- Check whether Gastroenteritis salmonella is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Mycophenolate mofetil:

Mycophenolate mofetil (93,460 reports)

Browse all side effects of Mycophenolate mofetil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Gastroenteritis salmonella:

Gastroenteritis salmonella (122 drugs)

Browse all the conditions that are associated with Gastroenteritis salmonella:

Gastroenteritis salmonella (261 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on mycophenolate mofetil (the active ingredients of Mycophenolate mofetil) and Mycophenolate mofetil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.